JP Morgan Chase
APXH

JP Morgan Chase’s APEX HealthCare ETF APXH Stock Holding History

JP Morgan Chase’s Portfolio APXH Stock Details APXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,499
Closed -$66K – 7523
2022
Q4 		$66K Buy
7,499
+678
+10% +$5.83K ﹤0.01% 5516
2022
Q3 		$54K Buy
6,821
+527
+8% +$4.49K ﹤0.01% 5525
2022
Q2 		$53K Sell
6,294
-1,205
-16% -$10.5K ﹤0.01% 5640
2022
Q1 		$70K Buy
+7,499
New +$69.1K ﹤0.01% 5657

JP Morgan Chase's APXH Position: Q1 2023 in Review

JP Morgan Chase sold out of APEX HealthCare ETF (APXH) in Q1 2023, closing a stake of 7,499 shares — an estimated $66K sold.

JP Morgan Chase first reported a position in APXH in Q1 2022 and held it in 4 quarters. The position peaked at $70K in Q1 2022. 0 funds tracked by Wall St. Rank hold APXH as of Q1 2023.

  • JP Morgan Chase reported no remaining APEX HealthCare ETF position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 7,499 APEX HealthCare ETF shares in Q1 2023, an estimated $66K.
  • JP Morgan Chase first reported a position in APEX HealthCare ETF in Q1 2022 and held it in 4 quarters.
  • JP Morgan Chase's APEX HealthCare ETF position peaked at $70K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held APEX HealthCare ETF as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.